In terms of secondary outcomes, our results have demonstrated that reduced levels of HGF was the only observed predictor of worsening PAD status (HR 0.71 [95% CI 0.16–0.88], adjusted HR 0.68 [95% CI 0.15–0.86]). Here, HGF is linked to peripheral arterial disease.